153 related articles for article (PubMed ID: 20488952)
1. Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis.
Behmoaras J; Smith J; D'Souza Z; Bhangal G; Chawanasuntoropoj R; Tam FW; Pusey CD; Aitman TJ; Cook HT
J Am Soc Nephrol; 2010 Jul; 21(7):1136-44. PubMed ID: 20488952
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat.
Reynolds J; Cook PR; Behmoaras J; Smith J; Bhangal G; Tadros S; Tee J; Salama AD; Evans DJ; Aitman TJ; Cook HT; Pusey CD
Am J Pathol; 2012 May; 180(5):1843-51. PubMed ID: 22445570
[TBL] [Abstract][Full Text] [Related]
3. Experimental crescentic glomerulonephritis: a new bicongenic rat model.
D'Souza Z; McAdoo SP; Smith J; Pusey CD; Cook HT; Behmoaras J; Aitman TJ
Dis Model Mech; 2013 Nov; 6(6):1477-86. PubMed ID: 24046355
[TBL] [Abstract][Full Text] [Related]
4. Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat.
Smith J; Lai PC; Behmoaras J; Roufosse C; Bhangal G; McDaid JP; Aitman T; Tam FW; Pusey CD; Cook HT
J Am Soc Nephrol; 2007 Jun; 18(6):1816-23. PubMed ID: 17475818
[TBL] [Abstract][Full Text] [Related]
5. Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility.
Behmoaras J; Bhangal G; Smith J; McDonald K; Mutch B; Lai PC; Domin J; Game L; Salama A; Foxwell BM; Pusey CD; Cook HT; Aitman TJ
Nat Genet; 2008 May; 40(5):553-9. PubMed ID: 18443593
[TBL] [Abstract][Full Text] [Related]
6. Identification of Ceruloplasmin as a Gene that Affects Susceptibility to Glomerulonephritis Through Macrophage Function.
Chen TD; Rotival M; Chiu LY; Bagnati M; Ko JH; Srivastava PK; Petretto E; Pusey CD; Lai PC; Aitman TJ; Cook HT; Behmoaras J
Genetics; 2017 Jun; 206(2):1139-1151. PubMed ID: 28450461
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the macrophage transcriptome in glomerulonephritis-susceptible and -resistant rat strains.
Maratou K; Behmoaras J; Fewings C; Srivastava P; D'Souza Z; Smith J; Game L; Cook T; Aitman T
Genes Immun; 2011 Mar; 12(2):78-89. PubMed ID: 21179115
[TBL] [Abstract][Full Text] [Related]
8. Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat.
Reynolds J; Albouainain A; Duda MA; Evans DJ; Pusey CD
Nephrol Dial Transplant; 2006 Dec; 21(12):3398-408. PubMed ID: 16998225
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats.
Ogawa D; Shikata K; Matsuda M; Okada S; Usui H; Wada J; Taniguchi N; Makino H
Nephrol Dial Transplant; 2002 Dec; 17(12):2117-21. PubMed ID: 12454221
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis.
Abraham AP; Ma FY; Mulley WR; Nikolic-Paterson DJ; Tesch GH
Nephrology (Carlton); 2018 Feb; 23(2):183-189. PubMed ID: 27862656
[TBL] [Abstract][Full Text] [Related]
12. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis.
Uchimura H; Marumo T; Takase O; Kawachi H; Shimizu F; Hayashi M; Saruta T; Hishikawa K; Fujita T
J Am Soc Nephrol; 2005 Apr; 16(4):997-1004. PubMed ID: 15744001
[TBL] [Abstract][Full Text] [Related]
13. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ
Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331
[TBL] [Abstract][Full Text] [Related]
14. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha.
Karkar AM; Smith J; Pusey CD
Nephrol Dial Transplant; 2001 Mar; 16(3):518-24. PubMed ID: 11239025
[TBL] [Abstract][Full Text] [Related]
16. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
Amos LA; Ma FY; Tesch GH; Liles JT; Breckenridge DG; Nikolic-Paterson DJ; Han Y
J Cell Mol Med; 2018 Sep; 22(9):4522-4533. PubMed ID: 29998485
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
Lan HY; Yang N; Metz C; Mu W; Song Q; Nikolic-Paterson DJ; Bacher M; Bucala R; Atkins RC
Mol Med; 1997 Feb; 3(2):136-44. PubMed ID: 9085256
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis.
Ogawa D; Shikata K; Matsuda M; Okada S; Wada J; Yamaguchi S; Suzuki Y; Miyasaka M; Tojo S; Makino H
Clin Exp Immunol; 2002 Jul; 129(1):43-53. PubMed ID: 12100021
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
20. Role of novel rat-specific Fc receptor in macrophage activation associated with crescentic glomerulonephritis.
Page TH; D'Souza Z; Nakanishi S; Serikawa T; Pusey CD; Aitman TJ; Cook HT; Behmoaras J
J Biol Chem; 2012 Feb; 287(8):5710-9. PubMed ID: 22184119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
